- Home
- KROS vs BKSY Comparison
KROS vs BKSY Comparison
Compare KROS & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- BKSY
- Stock Information
- Founded
- KROS 2015
- BKSY 2013
- Country
- KROS United States
- BKSY United States
- Employees
- KROS N/A
- BKSY N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- BKSY Radio And Television Broadcasting And Communications Equipment
- Sector
- KROS Health Care
- BKSY Technology
- Exchange
- KROS Nasdaq
- BKSY Nasdaq
- Market Cap
- KROS 565.0M
- BKSY 643.3M
- IPO Year
- KROS 2020
- BKSY N/A
- Fundamental
- Price
- KROS $15.66
- BKSY $19.31
- Analyst Decision
- KROS Buy
- BKSY Strong Buy
- Analyst Count
- KROS 14
- BKSY 6
- Target Price
- KROS $20.56
- BKSY $23.50
- AVG Volume (30 Days)
- KROS 430.7K
- BKSY 1.6M
- Earning Date
- KROS 11-05-2025
- BKSY 11-06-2025
- Dividend Yield
- KROS N/A
- BKSY N/A
- EPS Growth
- KROS N/A
- BKSY N/A
- EPS
- KROS 0.47
- BKSY N/A
- Revenue
- KROS $232,844,000.00
- BKSY $104,662,000.00
- Revenue This Year
- KROS $5,579.44
- BKSY $15.34
- Revenue Next Year
- KROS N/A
- BKSY $34.07
- P/E Ratio
- KROS $33.65
- BKSY N/A
- Revenue Growth
- KROS 85820.30
- BKSY N/A
- 52 Week Low
- KROS $9.12
- BKSY $3.86
- 52 Week High
- KROS $72.37
- BKSY $28.85
- Technical
- Relative Strength Index (RSI)
- KROS 59.38
- BKSY 59.11
- Support Level
- KROS $15.23
- BKSY $15.37
- Resistance Level
- KROS $15.85
- BKSY $17.02
- Average True Range (ATR)
- KROS 0.52
- BKSY 1.10
- MACD
- KROS 0.01
- BKSY 0.21
- Stochastic Oscillator
- KROS 72.91
- BKSY 97.79
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.